Skip to main content

Apyx Medical Corp

APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000719135

No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Apyx Medical Corp changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of APYX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders7475+1
Shares18.9M19.1M+225.0K (+1.2%)
Value$261.3M$244.9M−$16.4M (−6.3%)

New holders (8)

Institutions that held Apyx Medical Corp at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to APYX in Q4 2021
InstitutionSharesValue% of portfolio
Invenire Partners, LP348,007$4.46M4.72%
EAM Global Investors LLC122,181$1.57M0.28%
Allspring Global Investments Holdings, LLC73,728$945.0K0.00%
Raymond James & Associates15,325$196.0K0.00%
First Quadrant L P4,800$62.0K0.01%
Dorsey Wright & Associates3,989$51.0K0.01%
Spire Wealth Management1,000$13.0K0.00%
CWM, LLC37$00.00%

Sold out (7)

Institutions that held Apyx Medical Corp at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of APYX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Two Sigma Investments, LP26,643$369.0K
HRT Financial LP24,214$335.0K
Two Sigma Advisers, LP14,300$198.0K
Jane Street Group, LLC11,554$160.0K
Virtu Financial LLC10,784$149.0K
SG Americas Securities, LLC10,680$148.0K
Acadian Asset Management LLC4,508$62.0K